Change in MRI striatal volumes as a biomarker in preclinical Huntington's disease
暂无分享,去创建一个
[1] G. Pearlson,et al. Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.
[2] G. Pearlson,et al. Longitudinal change in basal ganglia volume in patients with Huntington's disease , 1997, Neurology.
[3] G. M. Halliday,et al. Regional Specificity of Brain Atrophy in Huntington's Disease , 1998, Experimental Neurology.
[4] J. Penney,et al. Trinucleotide repeat length instability and age of onset in Huntington's disease , 1993, Nature Genetics.
[5] S. Folstein,et al. Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease. , 1995, American journal of human genetics.
[6] Jane S. Paulsen,et al. Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.
[7] R. Ferrante,et al. Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.
[8] Jane S. Paulsen,et al. Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.
[9] A. Young,et al. Interrater agreement in the assessment of motor manifestations of Huntington's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.
[10] D. DeMets,et al. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.
[11] G. Pearlson,et al. Basal ganglia volume and proximity to onset in presymptomatic Huntington disease. , 1996, Archives of neurology.
[12] J. Brandt,et al. Onset and rate of striatal atrophy in preclinical Huntington disease , 2004, Neurology.
[13] J. Brandt,et al. When does Huntington's disease begin? , 1998, Journal of the International Neuropsychological Society.
[14] C A Ross,et al. Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. , 1993, Human molecular genetics.
[15] L. Raymond,et al. Caudate volume as an outcome measure in clinical trials for Huntington’s disease: a pilot study , 2003, Brain Research Bulletin.